卡马西平在混合性额叶和精神疾病中的应用。

J Clin Psychiatry. 1985 Sep;46(9):393-4.

Carbamazepine was given to five patients with mixed frontal lobe disease and a variety of primary psychiatric disorders. All five patients benefited significantly. A decrease in affective lability was the most consistent result. Carbamazepine may be an alternative to chronic high-dose neuroleptic therapy in these patients.

卡马西平被给予了五名患有混合性额叶疾病和多种原发性精神障碍的患者。所有五名患者均获益显著。情感不稳定性降低是最一致的结果。在这些患者中，卡马西平可能是慢性高剂量抗精神病药物治疗的替代选择。